← Back to headlines
Eli Lilly's Position in Obesity Drug Market
An analysis questions whether Eli Lilly maintains its leadership in the $150 billion obesity drug market.
4 Aug, 15:15 — 4 Aug, 15:15
Sources
Showing 1 of 1 sources
Related Stories
Taco Bell Returns to UAE After 14-Year Absence Amid GCC Expansion
34m ago
Malaysian Prime Minister Unveils New Economic Measures to Curb Living Costs
35m ago
Russia Escalates Gray Zone Operations Across Europe Amid Rising Tensions
1h ago
Malaysia Increases Subsidized Fuel Quotas Ahead of Independence Day
2h ago